These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11111251)

  • 1. The Ohio Substance Abuse Monitoring Network: constructing and operating a statewide epidemiologic intelligence system.
    Siegal HA; Carlson RG; Kenne DR; Starr S; Stephens RC
    Am J Public Health; 2000 Dec; 90(12):1835-7. PubMed ID: 11111251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring and reporting alcohol and drug use trends in California: the California Substance Abuse Research Consortium meetings.
    Finnerty BA
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():119-25. PubMed ID: 12825754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall gambling behaviors and gambling treatment needs among a statewide sample of drug treatment clients in Ohio.
    Sherba RT; Martt NJ
    J Gambl Stud; 2015 Mar; 31(1):281-93. PubMed ID: 23934370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing the Regional Epidemiological Outcomes Workgroup (REOW) in the State of Oklahoma for Substance Abuse Prevention: An ODMHSAS Project.
    Gurganus KM; Butt AL; Kirchenbauer CM; Melkvik C; Piatt J; Hawkins J; U'Ren S; Onuorah Y
    Community Ment Health J; 2015 Jul; 51(5):535-9. PubMed ID: 25536944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative needs assessment for child mental health program development.
    Wolf EM; Yung BR; Cotton KL
    J Ment Health Adm; 1994; 21(2):161-9. PubMed ID: 10133777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug abuse in Nepal: a rapid assessment study.
    Chatterjee A; Uprety L; Chapagain M; Kafle K
    Bull Narc; 1996; 48(1-2):11-33. PubMed ID: 9839033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug abuse as a public health problem in Ohio: a case report.
    Winstanley EL; Gay J; Roberts L; Moseley J; Hall O; Beeghly BC; Winhusen T; Somoza E
    Public Health Nurs; 2012 Nov; 29(6):553-62. PubMed ID: 23078426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statewide substance abuse prevention planning.
    Breer P; McAuliffe WE; Levine EB
    Eval Rev; 1996 Oct; 20(5):596-618. PubMed ID: 10183264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Needs assessment in demand reduction programmes with special reference to African countries.
    Adelekan M
    East Afr Med J; 1994 Jul; 71(7):432-6. PubMed ID: 7828495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model development for substance abusing surveillance system in communities.
    Damapong P; Tongkrajai P; Homchampa P; Kanato M
    J Med Assoc Thai; 2012 Feb; 95(2):241-8. PubMed ID: 22435255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The community epidemiology work group approach.
    Kozel NJ; Robertson EB; Falkowski CL
    Subst Use Misuse; 2002; 37(5-7):783-803. PubMed ID: 12117070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for substance abuse services and policy research: a systematic review of national databases.
    Coffey RM; Levit KR; Kassed CA; McLellan AT; Chalk M; Brady TM; Vandivort-Warren R
    Eval Rev; 2009 Apr; 33(2):103-37. PubMed ID: 19126788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid assessment of drug abuse in Kenya.
    Mwenesi HA
    Bull Narc; 1996; 48(1-2):65-78. PubMed ID: 9839036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency department surveillance: an examination of issues and a proposal for a national strategy.
    Garrison HG; Runyan CW; Tintinalli JE; Barber CW; Bordley WC; Hargarten SW; Pollock DA; Weiss HB
    Ann Emerg Med; 1994 Nov; 24(5):849-56. PubMed ID: 7978557
    [No Abstract]   [Full Text] [Related]  

  • 15. Methamphetamine use in Dayton, Ohio: preliminary findings from the Ohio Substance Abuse Monitoring Network.
    Daniulaityte R; Carlson RG; Kenne DR
    J Psychoactive Drugs; 2007 Sep; 39(3):211-21. PubMed ID: 18159774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol and drug abuse among Connecticut youth: implications for adolescent medicine and public health.
    Ungemack JA; Hartwell SW; Babor TF
    Conn Med; 1997 Sep; 61(9):577-85. PubMed ID: 9334513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why Don't Hospitals Prioritize Substance Abuse in Their Community Benefit Programming?
    Franz B; Skinner D; Kelleher K
    J Public Health Manag Pract; 2019; 25(1):62-68. PubMed ID: 29346190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid assessment of drug abuse in Cameroon.
    Wansi E; Sam-Abbenyi A; Befidi-Mengue R; Enyme FN; Ntone FN
    Bull Narc; 1996; 48(1-2):79-88. PubMed ID: 9839037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needs assessment in demand reduction programmes with special reference to African countries.
    Adelekan ML
    West Afr J Med; 1995; 14(2):91-6. PubMed ID: 7495721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.